Clinical Trial Update: Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating estramustine for breast cancer progression after aromatase inhibitor therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Estramustine (estramustine)

Snippet

Sponsor: Institut de Cancérologie de Lorraine | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED